As a recognized leader in the contract research organization (CRO) industry for conducting complex oncology trials, PharPoint Research has contributed expert services critical to the approval of many important oncology drugs. PharPoint Research has participated in 146 oncology studies in every phase and many indications, including oral mucositis, melanoma, chronic lymphocytic leukemia, myelofibrosis, and solid tumors. Our significant oncology therapeutic experience encompasses 44 oncology indications. We have provided biostatistics and data management services for dozens of these oncology trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for oncology studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.